Drug intelligence / Profile preview

Spermatech male contraceptive

Development stage
Preclinical
Lead developer
Spermatech
Modality
Small Molecules
01

Overview

Spermatech male contraceptive is a non-hormonal small molecule drug candidate being developed by Spermatech AS. The drug functions as an ATP inhibitor, specifically targeting the metabolic pathways responsible for ATP production within sperm cells. By depleting the energy supply required for flagellar movement, the compound significantly reduces sperm motility, thereby preventing fertilization. This approach aims to provide a reversible and localized contraceptive option for men without the systemic side effects associated with hormonal therapies. The program is currently in the preclinical stage of development, involving collaborations with the University of Oslo, SINTEF, and Evotec AG.

Other names
ATP inhibitor (Spermatech)sperm cell ATP inhibitor
02

Targets

GAPDHS (Glyceraldehyde-3-phosphate dehydrogenase, spermatogenic)

Beyond the preview

Go deeper on Spermatech male contraceptive.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Full profile access

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Full profile access

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Full profile access

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Full profile access

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Full profile access

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Spermatech male contraceptive.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call